We are monitoring the impact of COVID-19 on APAC Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 900
Share on
Share on

Asia Pacific Hormone Replacement Therapy Market Research Report - SegmentedBy Hormone Type, By Route Of Administration & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2019-2024)

Pulished: February, 2020
ID: 900
Pages: 135

APAC Hormone Replacement Therapy Market Size & Growth (2019 – 2024)

As per the research report, the size of the Asia-Pacific Hormone Replacement Therapy Market is valued at USD 2.21 billion in 2019 and is predicted to reach USD 3.24 billion by 2024, growing at a CAGR of 7.92% during the forecast 2019-2024.

Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs that require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of Asia-Pacific hormone replacement therapy market. Hormone Therapy (HT) remains the most effective option to treat menopausal symptoms. There are many good clinical data to indicate that the use of HT started in early menopause is effective and safe.

The major factor acting as a hurdle for market growth in the Asia-Pacific region is the cost of therapy. Normally, the therapy costs around $ 10,000. This is a pretty high amount considering the economic conditions of people in most of the countries in the Asia-Pacific region. Further, the risk of side effects, such as bloating, mood changes, and nausea, bleeding, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is restraining the growth of the Asia-Pacific market. Along with this, women with high susceptibility to coronary diseases are kept away from taking hormone replacement therapy.

This research report segmented and sub-segmented into the following categories:

  • By Hormone Type: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy, and others.
  • By Route of Administration: Oral, transdermal, parenteral, and other routes.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Japan holds the major share of the Asia-Pacific hormone replacement therapy market while India & China are expected to register high growth rates during the forecast period.

The Top companies leading in the APAC Hormone Replacement Therapy Market profiled in the report are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co, Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc

1.Introduction       

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions  

2. Research Methodology                

                2.1 Introduction   

                2.2 Research Phases        

                                2.2.1 Secondary Research                                            

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                     

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design           

                2.4 Study Timeline            

3. Overview           

                3.1 Executive Summary  

                3.2 Key Inferences           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers            

                4.2 Market Restraints      

                4.3 Key Challenges           

                4.4 Current Opportunities in the Market 

5. Market Segmentation                   

                 5.1 By Hormone Type     

                                5.1.1 Estrogen Replacement Therapy                                     

                                5.1.2 Growth Hormone Replacement Therapy                                   

                                5.1.3 Thyroid Replacement Therapy                                       

                                5.1.4 Others                                      

                5.2 By Route of Administration   

                                5.2.1 Oral                                            

                                5.2.2 Parenteral                               

                                5.2.3 Transdermal                                           

                                5.2.4 Others                                      

6. Geographical Analysis                   

                6.3 Asia-Pacific   

                                6.1 Introduction

                                6.2 China                                            

                                6.3 India

                                6.4 Japan                                            

                                6.5 South Korea                               

                                6.6 Australia                                      

7. Pipeline Product Analysis            

                7.1 Overview         

                7.2 Pipeline Development Landscape         

                7.3 Molecular Targets in the Pipeline                       

                7.4 Clinical Trials  

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target    

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target. 

8.Strategic Analysis             

                8.1 PESTLE analysis           

                                8.1.1 Political                                     

                                8.1.2 Economic                                 

                                8.1.3 Social                                         

                                8.1.4 Technological                                         

                                8.1.5 Legal                                          

                                8.1.6 Environmental                                      

                8.2 Porter’s Five analysis   

                                8.2.1 Bargaining Power of Suppliers                                        

                                8.2.2 Bargaining Power of Consumers                                    

                                8.2.3 Threat of New Entrants                                     

                                8.2.4 Threat of Substitute Products and Services                               

                                8.2.5 Competitive Rivalry within the Industry                                      

9.Market Leaders' Analysis               

                9.1 Abbott Laboratories 

                                9.1.1 Overview                                

                                9.1.2 Product Analysis                                   

                                9.1.3 Financial analysis                                  

                                9.1.4 Recent Developments                                       

                                9.1.5 SWOT analysis                                       

                                9.1.6 Analyst View                                          

                9.2 Novartis                                                       

                9.3 Pfizer 

                9.4 Mylan Laboratories   

                9.5 Amgen           

                9.6 Merck & Co. 

                9.7 Bayer 

                9.8 Eli Lily & Company    

                9.9 Novo Nordisk 

                9.10 Wyeth          

                9.11 F. Hoffmann-La Roche           

                9.12 Hisamitsu Pharmaceutical  Co. Inc.   

10.Competitive Landscape               

                10.1 Market share analysis            

                10.2 Merger and Acquisition Analysis       

                10.3 Agreements, collaborations and Joint Ventures         

                10.4 New Product Launches         

11.Expert Opinions              

                11.1 Market Outlook       

                11.2 Investment Opportunities   

Appendix                

                a) List of Tables  

                b) List of Figures   

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  2. Asia-Pacific Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  3. Asia-Pacific Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  4. Asia-Pacific Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  5. Asia-Pacific Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  6. Asia-Pacific Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  7. India Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  8. India Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  9. China Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  10. China Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  11. Japan Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  12. Japan Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  13. South Korea Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  14. South Korea Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  15. Australia Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  16. Australia Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample